Deerfield Management Discloses Stake In Post-IPO Audentes Therapeutics (BOLD)

Page 9 of 14

Page 9 of 14 – SEC Filing
CUSIP No.
05070R104
13G
Page 9 of 11 
       
(i)    o A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
       
(j)    o
A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
 
 
(k)    o
Group, in accordance with Rule 13d-1(b)(1)(ii)(K).
If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: _________________
Item 4.      Ownership. 
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a)
Amount beneficially owned**:
Deerfield Mgmt, L.P. –  514,424 shares
Deerfield Mgmt III, L.P. – 889,230 shares
Deerfield Management Company, L.P. –  1,403,654 shares
Deerfield Special Situations Fund, L.P. –  514,424 shares
Deerfield Private Design Fund III, L.P. – 889,230 shares
James E. Flynn –  1,403,654 shares
(b)
Percent of class**:
Deerfield Mgmt, L.P. – 2.45%
Deerfield Mgmt III, L.P. – 4.23%
Deerfield Management Company, L.P. – 6.68%
Deerfield Special Situations Fund, L.P. – 2.45%
Deerfield Private Design Fund III, L.P. – 4.23%
James E. Flynn – 6.68%
(c)
Number of shares as to which such person has**:
(i)
Sole power to vote or to direct the vote:
All Reporting Persons – 0
(ii)
Shared power to vote or to direct the vote:
Deerfield Mgmt, L.P. –  514,424 shares
Deerfield Mgmt III, L.P. – 889,230 shares
Deerfield Management Company, L.P. –  1,403,654 shares
Deerfield Special Situations Fund, L.P. –  514,424 shares
Deerfield Private Design Fund III, L.P. – 889,230 shares
James E. Flynn –  1,403,654 shares
      
(iii)
Sole power to dispose or to direct the disposition of:
All Reporting Persons – 0
(iv)
Shared power to dispose or to direct the disposition of:
Deerfield Mgmt, L.P. –  514,424 shares
Deerfield Mgmt III, L.P. – 889,230 shares
Deerfield Management Company, L.P. –  1,403,654 shares
Deerfield Special Situations Fund, L.P. –  514,424 shares
Deerfield Private Design Fund III, L.P. – 889,230 shares
James E. Flynn –  1,403,654 shares
**See footnotes on cover pages which are incorporated by reference herein.

Follow Audentes Therapeutics Inc. (NASDAQ:BOLD)

Page 9 of 14